News
NICE approves funding for Novartis gene therapy
NICE has published final draft guidance regarding the recommendation of routine NHS funding for onasemnogene abeparvovec.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
NICE has published final draft guidance regarding the recommendation of routine NHS funding for onasemnogene abeparvovec.